Brief: Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment
16/01/2025 13:36
Jan 16 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS ANNOUNCES NOTICE OF ALLOWANCE FOR NEW U.S. PATENT
APPLICATION COVERING USE OF FEMASEED® FOR FEMALE INFERTILITY
TREATMENT
* FEMASYS INC: EXPECTS RESULTING PATENT, WHEN ISSUED, WILL
HAVE AN
ANTICIPATED EXPIRATION IN 2044 AT EARLIEST
Source text: ID:nGNX5HkYtK
Further company coverage: FEMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview